Aurora Cannabis (NASDAQ:ACB – Get Free Report) will likely be announcing its earnings results before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Aurora Cannabis Price Performance
Shares of ACB opened at $3.75 on Wednesday. Aurora Cannabis has a fifty-two week low of $2.84 and a fifty-two week high of $9.35. The firm’s 50 day moving average price is $4.26 and its 200 day moving average price is $5.24. The company has a market cap of $205.73 million, a P/E ratio of -4.93 and a beta of 1.86. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07.
Analysts Set New Price Targets
ACB has been the topic of several recent research reports. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. TD Cowen initiated coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating on the stock.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- Using the MarketBeat Stock Split Calculator
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What to Know About Investing in Penny Stocks
- What Does the Future Hold for Eli Lilly?
- Ride Out The Recession With These Dividend Kings
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.